Tradestie Institutional Equity Comparison Engine

NMTC vs BVS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BVS Overall Edge

BVS Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Bioventus Inc. Class A Common Stock (BVS) driven by superior Valuation, Growth & Margin, Momentum & Technical while NMTC counters with relative strength in Options & Structure. Fundamentally, NMTC trades at N/M Forward P/E with -63.4% operating margin (+16.3% YoY revenue) versus BVS at 11.1x Forward P/E and 10.1% operating margin (+2.7% YoY). In options structure, NMTC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BVS sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner BVS
NMTC N/M vs BVS 11.1x Fwd P/E
Growth & Margin Winner BVS
Op Margin -63.4% vs 10.1% ยท YoY +16.3% vs +2.7%
Momentum & Technical Winner BVS
1Y +3.5% vs +47.0% ยท 52W Pos 2% vs 36%
Options & Structure Winner NMTC
UNCLASSIFIED (N/A IV) vs BREAKDOWN (100th %ile IV)
NMTC NASDAQ
NeuroOne Medical Technologies Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$0.65
-3.38% 1D
Market Cap $6.1M
1M Return -33.46%
1Y Return +3.49%
Forward P/E N/M
Unified AI Score
45.5 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 60.0 Mom 64.0
BVS NASDAQ
Bioventus Inc. Class A Common Stock
Surgical & Medical Instruments & Apparatus
$9.88
-0.7% 1D
Market Cap $681.3M
1M Return -34.31%
1Y Return +47.02%
Forward P/E 11.1x
Unified AI Score
46.2 / 100 HOLD
Tech 35.0 Fund 49.0 Flow 64.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NMTC +3.49% BVS +47.02% Spread: +43.53 pp (BVS Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period NMTC Revenue BVS Revenue NMTC Op. Margin BVS Op. Margin Margin Edge
FY2014 $0M N/A -4646.1% N/A NMTC
FY2019 N/A $340M N/A 9.2% BVS
FY2020 N/A $320M N/A 6.6% BVS
FY2021 $0M $430M -5735.9% 2.8% BVS
FY2022 $0M $510M -5860.2% -32.7% BVS
FY2023 $0M $510M -612.3% -16.0% BVS
FY2024 $0M $570M -344.3% -2.7% BVS
FY2025 $10M $570M -46.5% 9.5% BVS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NMTC (1) vs BVS (9)
Institutional Metric NMTC BVS Criterion Row Winner
Market Capitalization Scale $6.1M $681.3M Larger Scale BVS
Trailing P/E Ratio Valuation N/M 12.3x Lower Multiple BVS
Forward P/E Ratio Valuation N/M 11.1x Lower Multiple BVS
Revenue Growth (YoY) Growth +16.3% +2.7% Higher Growth NMTC
Operating Margin (TTM) Profitability -63.4% 10.1% Higher Margin BVS
Net Profit Margin Profitability -59.7% 9.8% Higher Margin BVS
Return on Equity (ROE) Capital Efficiency -124.7% 25.8% Higher ROE BVS
52-Week Range Position Momentum 2% ($1โ€“$5) 36% ($6โ€“$16) Stronger Trend BVS
Beta / 30D Volatility Risk Regime 1.55ฮฒ ยท 105% Vol 0.85ฮฒ ยท 74% Vol Lower Realized Risk BVS
Unified Institutional Score Composite Signal 45.5 / 100 (HOLD) 46.2 / 100 (HOLD) Higher Composite BVS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NMTC vs BVS Buy Guide
NMTC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NMTC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BVS BREAKDOWN
76d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live BVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NMTC nor BVS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.